Neumología

2022

1. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

   Thrombosis Journal, Vol. 20, Núm. 1

2. An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study

   Metabolites, Vol. 12, Núm. 12

3. Apnea Virtual Lab: A Community-Based Sleep Apnoea Management Programme

   Open Respiratory Archives, Vol. 4, Núm. 4

4. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

   Scientific Reports

5. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities

   International Journal of Infectious Diseases, Vol. 115, pp. 39-47

6. Bacteremic pneumococcal pneumonia: arrhythmogenic disease

   Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

7. COPD in SARS-CoV-2 pandemic. baseline characteristics related to hospital admissions

   Expert Review of Respiratory Medicine, Vol. 16, Núm. 4, pp. 477-484

8. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

   Infection, Vol. 50, Núm. 1, pp. 179-189

9. Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism

   Cancers, Vol. 14, Núm. 17

10. Changes in health-related quality of life as a marker in the prognosis in COPD patients

    ERJ Open Research, Vol. 8, Núm. 1

11. Clinical, esthetic, and quality of life outcomes after telegnathic surgery in Caucasian OSAS patients

    Cranio - Journal of Craniomandibular and Sleep Practice, Vol. 40, Núm. 5, pp. 425-432

12. Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort

    Respiratory Medicine, Vol. 200

13. Descripción de las Unidades de Cuidados Respiratorios Intermedios (UCRI) antes y durante la pandemia SARS CoV 2

    Revista española de patología torácica, Vol. 34, Núm. 1, pp. 76-76

14. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

15. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 135-141

16. Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPD

    International journal of chronic obstructive pulmonary disease, Vol. 17, pp. 3033-3044

17. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

18. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

19. Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model

    Frontiers in Cardiovascular Medicine, Vol. 9

20. Effect of rapid maxillary expansion on the apnoea-hypopnoea index during sleep in children. Systematic review

    Journal of Clinical and Experimental Dentistry, Vol. 14, Núm. 9, pp. 769-775